Analyst consensus rating
Opus Genetics Analyst Rating: Strong Buy
IRD is rated Strong Buy by 18 analysts with a $10.61 target. As of 2026-08-19.
Direct answer
Opus Genetics's consensus rating is Strong Buy.
18 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.61.
Forecast evidence checked August 19, 2026.
Get free Opus Genetics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.06
- Average price target
- $10.61
- High price target
- $16.00
- Low price target
- $8.00
- Low target gap
- +97.3%
- Target upside
- +161.7%
- High target gap
- +294.6%
- Target range width
- 197.3%
- Consensus rating
- Strong Buy
- Analysts
- 18
- Evidence date
- August 19, 2026
- Valid through
- August 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Opus Genetics?
Opus Genetics has a verified Strong Buy consensus. The same dataset has an average price target of $10.61.
How far are Opus Genetics's low and high targets from the recorded price?
The low target implies +97.3%, while the high target implies +294.6%.
How many analysts are included in Opus Genetics's consensus?
The verified consensus includes 18 analysts.
How is Opus Genetics's target upside or downside calculated?
The average target of $10.61 is divided by the recorded price of $4.06, then one is subtracted to produce +161.7%. This does not guarantee a future return.
When was Opus Genetics's analyst forecast verified?
The data was verified on 2026-08-19. The dataset is valid through 2026-08-26.